DRL launches Chlorthalidone tablets in US Markets

Dr Reddy’s Laboratories has launched Chlorthalidone tablets which is used to treat high blood pressure, in the US market. The drug will be made available in strengths of 25 mg and 50 mg.

The drug is a therapeutic equivalent generic version of Hygroton tablets. According to market estimates, the drug has US sales of approximately $122 million for the 12 months ended September 30, 2018.

Company Profile : Dr Reddys Laboratories Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.